Company intelligence / Profile preview

Prana Thoracic

Houston, Texas, United Statespranasurgical.com ↗

Ownership: Private
Employees: ~6
Development stage: Preclinical

Overview

The company has developed a minimally invasive electrosurgical device ("ThoraCore system"/"Prana System") designed for single-port excision of targeted lung tissue. It uses bipolar radiofrequency ablation to seal incisions and minimize complications. Large animal testing has been completed; first-in-human clinical studies are planned for late 2024. No published human clinical results yet.

Therapeutic areas: Oncology
Modalities: DeviceElectrosurgical instrument (specifically radiofrequency-based)
Industry: Surgical Medical Devices

Partnerships

Precision Thoracic Corporation (technology collaboration/development)Texas Medical Center Venture Fund

Beyond the preview

Go deeper on Prana Thoracic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prana Thoracic.

Explore the full profile